Skip to search formSkip to main contentSkip to account menu

0.09 ML pegaptanib 3.33 MG/ML Prefilled Syringe [Macugen]

Known as: 0.09 ML Macugen 3.33 MG/ML Prefilled Syringe, Macugen 3.33 MG/ML Prefilled Syringe, 90 MCL, PEGAPTANIB SODIUM 3.47 mg in 1 mL INTRAVITREAL INJECTION, SOLUTION [Macugen] 
National Institutes of Health

Related topics

Related topics

9 relations
Hydrochloric AcidMacugenPegaptanib SodiumPrefilled Syringe

Broader (1)

pegaptanib Prefilled Syringe [Macugen]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Monotherapie der exsudativen altersbedingten Makuladegeneration bei kardiovaskulären Risikopatienten
ZusammenfassungHintergrundMit der intravitrealen Applikation von Ranibizumab (Lucentis®) oder Pegaptanib (Macugen®) stehen… 
2009
2009
[Initial and unique treatment of macular edema due to branch retinal vein occlusion with antiangiogenic agents. A comparative pilot study].
Dear Sir, Macular edema (ME) is the main cause of loss of vision associated to non-ischemic occlusion of the retinal venous… 
2006
2006
Evaluation of Intravitreal Application of Pegaptanib Sodium (Macugen®) on Laser–Induced CNV in Cynomolgus Monkeys
2006
2006
[Pegaptanib (Macugen®) for age-related macular degeneration (AMD)]